Secretory leukocyte protease inhibitor and psoriasis

[Fred]

This study tried to understand secretory leukocyte protease inhibitor (SLPI) and psoriasis.

Quote:

---

Background
Secretory leukocyte protease inhibitor (SLPI), a ~12 kDa protein is an important regulator of innate and adaptive immunity and a component of tissue regenerative programs. SLPI expression is markedly elevated in chronically inflamed skin, including that of individuals suffering from psoriasis. However, the role of SLPI in these diseases remains elusive.

Objectives
The poor understanding of the early stages of the development of psoriasis is a major obstacle to successful intervention in the skin pathology. We hypothesized that SLPI and peripheral nerves that might be activated early in the progression of the disease likely form a functional relationship to maintain skin barrier homeostasis and respond to a variety of threats.

Methods
We used skin biopsies of healthy donors and individuals with psoriasis to show expression pattern of SLPI. A role of SLPI in psoriasis was mechanistically assessed using SLPI deficient mice and an imiquimod-induced experimental model of psoriasis.

Results
We show that mice lacking SLPI had exaggerated skin alterations that extended beyond the treatment site in an imiquimod-induced psoriasis. The spatiotemporally distinct skin responses in SLPI deficient mice, compared to their wild-type littermates, resulted from a compromised skin barrier function that manifested itself in heightened transepidermal water loss through the larger skin area surrounding the imiquimod challenged skin. The increased pathogenic skin changes in the absence of SLPI were reversible through pharmacological treatment that blocks a nerve-reflex arc.

Conclusions
Together these data indicate that SLPI plays a protective role in psoriasis through preventing skin dryness, inherent in the pathogenesis of psoriasis, and that this SLPI action depends on neuronal input operating in a reflex manner. These findings reveal a previously unrecognized mechanism that maintains cutaneous homeostasis which involves a crosstalk between the nervous system and a protein anatomically poised to fortify the epidermal permeability barrier.

Source: onlinelibrary.wiley.com

*Early view funding unknown 

[Caroline]

Well that is all zooming in to extreme detail of the skin.

But… as we know that psoriasis is a system disease, I do suspect that this detail is a derivative effect that evolves in the whole process of having psoriasis.
I do not see at this point that the research can lead to new medication.
Though it does tell us more on what happens with the disease..



Jim, will be interested as it concerns mice.

[jiml]

Well that is all zooming in to extreme detail of the skin.

But… as we know that psoriasis is a system disease, I do suspect that this detail is a derivative effect that evolves in the whole process of having psoriasis.
I do not see at this point that the research can lead to new medication.
Though it does tell us more on what happens with the disease..



Jim, will be interested as it concerns mice.